Rheological study of the dynamic process of fibrinolysis

Blood Coagulation and Fibrinolysis

Volumn 8, Issue 6, 1997, Pages 351-359

  Kawakami, S ^a   Kaibara, M ^b   Nakayama, M ^b   Isogai, Y ^a   Ikemoto, S ^a   O'Rear, E A ^c   Lee, J S ^d  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^c University of Oklahoma   (United States)

^d Gwangju Institute of Science and Technology (GIST)   (South Korea)

Author keywords

Fibrin network structure; Fibrinolysis; Rheology; Tissue plasminogen activator

Indexed keywords

ALTEPLASE; FIBRIN; PROTHROMBIN; REAGENT;

ADULT; ARTICLE; BLOOD RHEOLOGY; CONTROLLED STUDY; DYNAMICS; FIBRIN CLOT; FIBRINOLYSIS; HUMAN; HUMAN TISSUE; NORMAL HUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

EID: 0030882625     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199709000-00005     Document Type: Article

References (32)

1. Collen D, Lijnen HR. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy. Tbromb Haemost 1995; 74: 167-171.
2. Reddy KNN, Markus G. Mechanism of activation of human plasminogen by streptokinase. J Biol Chem 1972; 247: 1683-1691.
3. Schick LA, Castellino FJ. Interaction of streptokinase and rabbit plasminogen. Biochem 1973; 12: 4315-4321.
4. Rijken DC, Hoylaerts M, Collen D. Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator. J Biol Chem 1982; 257: 2920-2925.
5. Stump DC, Topol EJ, Chen AB, Hopkins A, Colle D. Monitoring of hemostasis parameters during coronary thrombolysis with recombinant tissue-type plasminogen activator. Tbromb Haemost 1988; 59: 133-137.
6. Marder VJ, Bell WR. Fibrinolytic therapy. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia: JB Lippincott, 1987; 1397-1437.
7. Sheehan FH, Braunwald E, Canner P, Dodge HT, Gore J, Natta PV, et al. The effect of intravenous thrombolytic therapy on left venticular function: a report on tissue-type plasminogen activator and streptokinase from the thrombolysis in myocardial infarction (TIMI Phase I) trial. Circulation 1987; 75: 817-829.
8. Yusuf S, Collins R, Petro R, Furberg C, Stampfer MJ, Goldhaber SZ, Hennekens CH. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side effects from 33 randomized trials. Eur Heart J 1985; 6: 556-585.
9. Marder VJ, Sherry S. Thrombolytic therapy: current status. N Eng J Med 1988; 318: 1512-1591.
10. Williams DO, Borer J, Braunwald E, Chesebro JH, Cohen LS, Dalen J, et al. Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from NHLBI thrombolysis in myocardial infarction trial. Circulation 1986; 73: 338-346.
11. McIntire LV. Dynamic materials testing: biological and clinical applications in network-forming systems. Ann Rev Fluid Mech 1980; 12: 159-179.
12. Kaibara M, Fukada E. Rheology of blood clotting. Polym Eng Rev 1983; 3: 383-420.
13. Kirkpatrick JP, McIntire LV, Moake JL. Streptokinase-induced degradation of crosslinked and uncrosslinked clots. Thromb Res 1978; 13: 569-575.
14. Kirkpatrick JP, McIntire LV, Moake JL, Peterson DL. Dynamic rheological studies of coagulation and fibrinolysis. J Rheology 1979; 23: 769-787.
15. Nguyen PD, O'Rear EA, Johnson AE, Lu R, Fung BM. Thrombolysis using liposomal-encapsulated streptokinase: an in vitro study. PSEBM 1989; 192: 261-269.
16. Kaibara M, Date M. A new rheological method to measure fluidity change of blood during coagulation: application to in vitro evaluation of anticoagulability of artificial materials. Biorheology 1985; 22: 197-208.
17. Kaibara M, Kawamoto Y. Rheological measurement of blood coagulation in vascular vessel model tube consisting of endothelial cell monolayer. Biorheology 1991; 28: 263-274.
18. Murata T, Date M, Kaibara M. Analysis of a newly developed damped-oscillation rheometer. Newtonian liquid. Jap J Appl Phys 1987; 26: 1234-1240.
19. Glover CJ, McIntire LV, Brown III CH, Natelson EA. Rheological properties of fibrin clots. Effects of fibrinogen concentration, factor XIII deficiency, and factor XIII inhibition. J Lab Clin Med 1975; 86: 644-656.
20. Kaibara M, Fukada E, Sakaoku K. Rheological study on network structure of fibrin clots under various conditions. Biorheology 1981; 18: 22-35.
21. Nakamura Y. Analysis of damping factor (DF) curve and clinical application of damped oscillation rheometer. J Aichi Med Univ Assoc 1990; 18: 353-369.
22. Kawamoto Y, Kaibara M. Viscoelasticity of fibrin solution and of blood during coagulation studies by a new damped oscillation rheometer. Biorheology 1988; 25: 289-296.
23. Kaibara M. Rheological studies on blood coagulation and network formation of fibrin. Polym Gels and Networks 1994; 2: 1-28.
24. Kawakami S, Kaibara M, Kawamoto Y, Yamanaka K. Rheological approach to the analysis of blood coagulation in endothelial cell-coated tubes: activation of the intrinsic reaction on the erythrocyte surface. Biorheology 1995; 32: 521-536.
25. Margolis J. Glass surface and blood coagulation. Nature 1956; 178: 805-806.
26. McIntire LV, Kuntamukkula MS, Moake JL, Petersen DM. The use of rheological techniques to evaluate platelet function alterations caused by drug therapy. AlChE Symposium Series 1978; 74: 74-80.
27. Cohen I, Gerrard JM, White JG. Ultrastructure of clots during isometric contraction. J Cell Biology 1982; 93: 775-787.
28. Dintenfass L. Blood Microrheology - Viscosity Factor in Blood Flow, Ischemia and Thrombosis. Butterworths: London, 1971.
29. Passamani E, Hodges M, Herman M, Crose R, Chaitman B, Rogers W, et al. The thrombolysis in myocardial infarction (TIMI) phase II pilot study: tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1987; 10: 51B-64B.
30. Collen D, Stassen JM, Marafino J Jr, Builder S, De Cock F, Ogez J, et al. Biological properties of human tissue-type plasminogen activator obtained by expression of recombinant DNA in mammalian cells. J Pharmacol Exp Ther 1984; 231: 146-152.
31. Rijken DC, Collen D. Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. J Biol Chem 1981; 256: 7035-7041.
32. Hoylaerts M, Rijken DC, Lijnen HR, Collen D. Kinetics of the activation of plasminogen by human tissue plasminogen activator (role of fibrin). J Biol Chem 1982; 257: 2912-2919.